There are currently no pharmacoepidemiological data on the use of ADHD medications in Poland. Moreover, evidence from Central and Eastern Europe remains limited, despite a global increase in ADHD diagnosis and pharmacological treatment. This lack of evidence highlights the need for population-based analyses of prescribing trends in this setting. This study aims to analyze data from the Polish prescription register to estimate the increase in the total number of prescriptions for methylphenidate…
